Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business ...

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic

Related Keywords

Danielle Spangler ,Nasdaq ,Exchange Commission ,Reneo Pharmaceuticals Inc ,Reneo Pharmaceuticals ,Fourth Quarter ,Full Year ,Private Securities Litigation Reform Act ,Ended December ,Nation World ,Region ,